Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery?

Key Takeaways Revvity will report Q4 results on Feb. 2, with revenue expected to rise 5.2% year over year.RVTY's Life Sciences unit shows early demand recovery, driven by software growth and better instrument trends.RVTY's Diagnostics demand outside China is solid, but China reimbursement pressure remains a concern.Revvity, Inc. (RVTY) is slated to report fourth-quarter 2025 results on Feb. 2, before market open.In the last reported quarter, the company delivered an earnings surprise of 3.51%. RVTY’s earnin ...